Baird Medical Investment Holdings LTD 20-F annual reports
The annual report filed by foreign private issuers listed on a US exchange — the 10-K’s equivalent for non-US companies.
NASDAQ
Baird Medical Investment Holdings Limited's Form 20-F/A filing reveals a substantial revenue decline in 2025, driven by slower hospital purchasing, alongside a significant increase in R&D expenses.
NASDAQ
Baird Medical Investment Holdings Limited has entered into an Indemnity Agreement with Gabrielle Wolfson, outlining terms for indemnification and expense advancement for services rendered to the company.
NASDAQ
20-F: Baird Medical Investment Holdings Limited Navigates Key Regulatory and Financial Milestones in 2024
Baird Medical Investment Holdings Limited reports on its 20-F filing, highlighting regulatory compliance, financial performance, and strategic business activities for the fiscal year ended December 31, 2024.